The pursuit for the first approved longevity drug to treat the mechanisms of aging has never been more exciting with our understanding of the underlying biology of aging evolving and many innovative therapeutic options making significant preclinical and clinical progress.

The unmissable 4^th Annual Longevity Therapeutics Summit is returning in-person to San Francisco where it remains the only industry meeting uniting 100+ leading biotech/pharma drug developers, pioneering academics, and prominent investors striving to develop effective, novel anti-aging drugs and overcome major preclinical, translational, clinical, and regulatory obstacles.

With over 10 hours dedicated solely to in-person networking and discussion, this is your must-attend meeting of 2022 to reunite with your peers in the longevity field and share your ideas and opinions.